Almirall
Pharmaceutical company Almirall SA, makes allergy and respiratory, cardiovascular, central nervous system, digestive, infectious disease, oncology, osteomuscular, pediatric, and urology drugs.
Headquartered in Barcelona, the company provides medicines through its own R&D, agreements and alliances. The company was founded in 1943 and is listed on the Spanish Stock Exchange.
The company has over 2,100 employees, and has gradually built presence across Europe, as well as in the US and Mexico.
Latest Almirall News & Features
13 May 2024
19 February 2024
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze